CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,614
- in 3 filings
Net −$395,614. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | WONG RODERICK Director | Grant or award · Stock Option (Right to Buy) | +23,944 | 23,944 | ||
| 2024-06-13 | WONG RODERICK Director | Grant or award · Stock Option (Right to Buy) | +3,325 | $15.04 | $50K | 3,325 |
| 2024-06-13 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (Right to Buy) | +23,944 | 23,944 | ||
| 2024-06-13 | Yalamanchi Naveen Director | Grant or award · Stock Option (Right to Buy) | +23,944 | 23,944 | ||
| 2024-06-13 | Malik Fady Ibraham Director | Grant or award · Stock Option (Right to Buy) | +23,944 | 23,944 | ||
| 2024-06-13 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +23,944 | 23,944 | ||
| 2024-06-13 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +2,660 | $15.04 | $40K | 2,660 |
| 2024-06-13 | GRANADILLO PEDRO P Director | Grant or award · Stock Option (Right to Buy) | +23,944 | 23,944 | ||
| 2024-06-13 | GRANADILLO PEDRO P Director | Grant or award · Stock Option (Right to Buy) | +4,655 | $15.04 | $70K | 4,655 |
| 2024-06-13 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +23,944 | 23,944 | ||
| 2024-05-17 | Schwartz Jonathan David See Remarks | Sale | −2,754 | $23.35 | $64K | 169,659 |
| 2024-05-16 | Militello John See Remarks | Sale | −1,079 | $23.35 | $25K | 53,327 |
| 2024-05-16 | Shah Gaurav CEO | Sale | −9,790 | $23.35 | $229K | 728,069 |
| 2024-05-16 | Wilson Martin General Counsel | Sale | −1,048 | $23.35 | $24K | 65,762 |
| 2024-05-16 | Patel Kinnari See Remarks | Sale | −4,046 | $23.35 | $94K | 400,972 |
| 2024-05-14 | Shah Gaurav CEO | Option exercise | +7,979 | 636,451 | ||
| 2024-05-14 | Shah Gaurav CEO | Option exercise | +9,683 | 646,134 | ||
| 2024-05-14 | Shah Gaurav CEO | Option exercise · Restricted Stock Units | −7,979 | 23,940 | ||
| 2024-05-14 | Shah Gaurav CEO | Option exercise · Restricted Stock Units | −9,683 | 67,785 | ||
| 2024-05-14 | Wilson Martin General Counsel | Option exercise | +2,420 | 21,100 |
Page 10 of 19 · 374 trades